|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/768 | (2015.01) |
| A61K 35/761 | (2013.01) | ||
| A61K 35/761 | (2015.01) | ||
| A61K 35/768 | (2013.01) | ||
| A61K 35/763 | (2015.01) | ||
| A61P 35/00 | (2018.01) | ||
| C12N2710/24132 | (2013.01) | ||
| A61K 35/765 | (2015.01) | ||
| A61K 35/766 | (2015.01) | ||
| C12N2710/10332 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 35/766 | (2013.01) | ||
| C12N 7/00 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| C12R 1/93 | (2006.01) | ||
| A61K 39/4613 | (2023.05) | ||
| A61K2239/55 | (2023.05) | ||
| A61K 39/4644 | (2023.05) | ||
| A61K2239/54 | (2023.05) | ||
| A61K2239/50 | (2023.05) | ||
| A61K2239/38 | (2023.05) | ||
| A61K2239/53 | (2023.05) |
| (11) | Patento numeris | 3566709 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18736087.0 |
| Europos patento paraiškos padavimo data | 2018-01-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2018/070172 |
| Data | 2018-01-03 |
| (87) | Numeris | WO 2018/127053 |
| Data | 2018-07-12 |
| (30) | Numeris | Data | Šalis |
| 201710003954 | 2017-01-04 | CN |
| (72) |
HU, Fang , CN
CHEN, Lin , CN
ZHAO, Ronghua , CN
|
| (73) |
Hangzhou Converd Co., Ltd. ,
7th Floor, Building No.4,
2959 Yuhangtang Road,
Yuhang District, Hangzhou, Zhejiang 311121,
CN
|
| (54) | THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS |
| THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS |